YAGO NIETO to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications YAGO NIETO has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.188
-
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation. Blood. 2019 07 04; 134(1):22-29.
Score: 0.073
-
Idiopathic hyperammonemia following high-dose chemotherapy. Bone Marrow Transplant. 2006 May; 37(9):899.
Score: 0.030
-
Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancer. Clin Cancer Res. 2004 Nov 01; 10(21):7136-43.
Score: 0.027
-
Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma. Transplant Cell Ther. 2022 01; 28(1):32.e1-32.e10.
Score: 0.022
-
Vedolizumab for Steroid Refractory Lower Gastrointestinal Tract Graft-Versus-Host Disease. Transplant Cell Ther. 2021 03; 27(3):272.e1-272.e5.
Score: 0.020
-
Preliminary results of the combination of bevacizumab and weekly Paclitaxel in advanced melanoma. Oncology. 2008; 74(1-2):12-6.
Score: 0.009
-
Response of resistant melanoma to a combination of weekly paclitaxel and bevacizumab. Clin Transl Oncol. 2007 Feb; 9(2):119-20.
Score: 0.008